Member Info for jollygoodya

At this stage of the cycle, very difficult to put a valuation on. All about product cycle, forecasts/projections, demand and scalability.
Key thing is product, quality and the market/industry size. CBD related market audience is huge. It's a multibillion dollar segment. For me Zoe products are on point for the intended market. All about grabbing market share. This aspect is on the cards and on scale from today imo.

Mulltetman, I 've read today's RNS and on the face of it, it's a game changer and a watershed moment for Zoetic. Has the opportunity to be a household brand given the mass marketing that goes with this deal. Product has well received so far. I like the fact that the BoD appear to be on the ball so far as quality maintainence aspect too. The opportunity to be a household brand cannot be under stated. This is a company maker imo.

Makes sense to identify the need and roll out and prioritise based on the need. Depends on the cost per head of the vaccine. With vaccine in short supply a pre-test is lkely the way to go to preserve supplies.

Spot JAdam, nothing more to add. Selective reading is the norm.

3 billion vaccines on pre-order. Min tests 2 to 1. Big question is how much can we muster. Not simply a case of ramping up production but also porcurment of the necessary materials. Worldwide demand for the materials will be huge.

Walbrook appear to be gagged. Like everyone in the consortium. We blame them, however if I was walbrook, I'd be doing what the paymasters set out ;) personally think there's a lot of background work being done and we'll see a raft of postive news. When is anyone's guess. However our Q4 will be pivotal imo.

Flashy500, personally whilst I was and am not happy with the ipo. I can see the positive side to it so long as the UKRTC contract is upheld. It's an international level agreement amongst the partners. I'd like CK to engage with Abingdon with an independent contractual agreement. I can see your view point. Odx being an independent company is acting like a subordinated company. Intrigued by the persistant buys and lack of TR1/s. Also same games by MMs take it down as someone adds big then push back up. Market hates uncertainty.

Can someone re-post that dotted ODX rocket please :))

Need to continue to be patient, market forces at play. Not expecting anything amazing on interims, CK can put some forward estimates, but doubt he will. Looking at Q4 to make a big difference. Hopefully there will be upgraded guidance post new year. Meantime sp can do whatever and we can blame anything on earth but ourselves? After all we all pulled the buy triggers. Just be patient, all the news is out there, hell even the dots have been connected for us!

They've already given guidance on the last update.So expect interims to be naff.

How many listed diagnostics companies are in the frame with what has been stated by Bojo & co? Not many. Only one real contender with the connections of the likes of mologic and Abingdon.

Upomega, very possible. Concert parties a good way to mask things. Intriguing, just like the timing of the planned Abingdon ipo. Let's see what follows. Us pi's are mostly kept in the dark. Remember you also have the unidentified individual who provided funds too..

That we've not had any TR1/s. Sneller sold his lot; L&G sold out quite a lot if not all. Impossible for Pi's to buy that much. So who bought them all?

Kiwi, I'd agree with that.

Did say imminent news earlie, lol but this imminent!!
Not selling anything under a £1. Approvals just keep on rolling. Commercialisation on target. This is likely gonna get taken out, but at what price?

Iq-ai have a look target £1 min

Fig, certainly will be a very "jollygoodyear" but before that a very merry Xmas for ODX holders :)))))

Kiwi, this is going to blow, news imminent.

Fig, never ceases to amaze me how on vaccine news the sp is dropped for share collection purposes and eventually pulled back up. As people in the know willing to add :)

Figtree, spot on. There are many variation to the tests needed. Test redundancy does not exist. The market is absolutely huge. Most form of tests will fit in varying needs and circumstances. Buy, hold or add imo. ODX will be in demand.